These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
¨
|
|
Preliminary Proxy Statement
|
|
|
|
|
|
¨
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
|
ý
|
|
Definitive Proxy Statement
|
|
|
|
|
|
¨
|
|
Definitive Additional Materials
|
|
|
|
|
|
¨
|
|
Soliciting Material Pursuant to §240.14a-12
|
|
ý
|
|
No fee required
|
|||
|
¨
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11
|
|||
|
|
|
(1
|
)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2
|
)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3
|
)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4
|
)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5
|
)
|
|
Total fee paid:
|
|
¨
|
|
Fee paid previously with preliminary materials.
|
|||
|
¨
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|||
|
|
|
(1
|
)
|
|
Amount Previously Paid:
|
|
|
|
(2
|
)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
(3
|
)
|
|
Filing Party:
|
|
|
|
(4
|
)
|
|
Date Filed:
|
|
|
|
|
|
Table of Contents
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Elect four Class II Directors for a three year term;
|
|
(2)
|
Ratify the Audit Committee’s selection of Ernst & Young LLP as the Independent Registered Public Accounting Firm to audit Univar’s financial statements for the year ending
December 31, 2017
;
|
|
(3)
|
Vote, on an advisory basis, regarding the compensation of the executive officers described in Univar’s Proxy Statement;
|
|
(4)
|
Approval of the Univar Inc. 2017 Omnibus Equity Incentive Plan;
|
|
(5)
|
Approval of the Univar Inc. Executive Annual Bonus Plan; and
|
|
(6)
|
Transact any other business properly brought before the meeting.
|
|
Proposal
|
Board’s Recommendation
|
Page Reference
|
|
Election of four Class II Directors
|
FOR
|
22
|
|
Ratification of Ernst & Young LLP as Univar’s Independent Registered Public Accounting Firm for 2017
|
FOR
|
30
|
|
Advisory vote regarding the compensation of our executive officers
|
FOR
|
76
|
|
Approval of the Univar Inc. 2017 Omnibus Equity Incentive Plan
|
FOR
|
77
|
|
Approval of the Univar Inc. Executive Annual Bonus Plan
|
FOR
|
87
|
|
Name
|
Director Since
|
Board Committees
|
|
Daniel P. Doheny
|
2016
|
Audit
|
|
Edward J. Mooney
|
2016
|
Compensation
|
|
Juliet Teo
|
2015
|
n/a
|
|
David H. Wasserman
|
2010
|
Compensation
|
|
•
|
The election of four Class II Directors to serve until the 2020 Annual Meeting of the Company’s shareholders and until their successors are duly elected and qualified;
|
|
•
|
The ratification of the Audit Committee’s selection of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending
December 31, 2017
;
|
|
•
|
A non-binding advisory vote regarding the compensation of the executive officers described in this Proxy Statement;
|
|
•
|
Approval of the Univar Inc. 2017 Omnibus Equity Incentive Plan; and
|
|
•
|
Approval of the Univar Inc. Executive Annual Bonus Plan.
|
|
•
|
By Internet—If you have Internet access, the Board encourages you to vote on www.proxyvote.com by following instructions on the Notice or proxy card;
|
|
•
|
By Telephone—As instructed on the Notice or proxy cards by making a toll-free telephone call from the U.S. or Canada to 1 (800) 690-6903; or
|
|
•
|
By Mail—If you received your proxy materials by mail, you can vote by completing, signing and returning the enclosed proxy card in the postage-paid envelope provided.
|
|
•
|
signing another proxy card with a later date and returning it to the Company prior to the meeting;
|
|
•
|
giving written notice to the Secretary of the Company;
|
|
•
|
voting again at the meeting if the shares are registered in your name; or
|
|
•
|
voting again by Telephone or through the Internet prior to 11:59 p.m., Eastern Daylight Saving Time, on
May 3, 2017
.
|
|
•
|
FOR
the election of each of the nominees for director named in this proxy statement: Mr. Daniel P. Doheny, Mr. Edward J. Mooney, Ms. Juliet Teo, and Mr. David H. Wasserman;
|
|
•
|
FOR
the ratification of the Audit Committee’s selection of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the year ending
December 31, 2017
;
|
|
•
|
FOR
the approval, on an advisory basis, of the compensation of the executive officers described in this proxy statement;
|
|
•
|
FOR
Approval of the Univar Inc. 2017 Omnibus Equity Incentive Plan; and
|
|
•
|
FOR
Approval of the Univar Inc. Executive Annual Bonus Plan.
|
|
|
Audit Committee
|
Compensation Committee
|
Nominating and Corporate
Governance Committee
|
|
Richard P. Fox
|
C
|
|
M
|
|
Christopher D. Pappas
|
|
M
|
M
|
|
Daniel P. Doheny
|
M
|
|
|
|
David H. Wasserman
|
|
C
|
|
|
William S. Stavropoulos
1
|
|
|
C
|
|
Edward J. Mooney
|
|
M
|
|
|
Robert L. Wood
|
M
|
|
|
|
|
|
|
|
Name of Committee and Members
|
Representative Functions of the Audit Committee
|
Number of
Meetings in
2016
|
|
Audit:
Richard P. Fox, Chairman
Daniel P. Doheny
Robert L. Wood
|
•
make decisions about the appointment or replacement of an Independent Registered Public Accounting Firm (the “independent auditor”);
•
pre-approve any work performed by such independent auditor;
•
assist the Board in monitoring the integrity of the Company’s financial statements, the independent auditor’s qualifications and independence, the performance of the independent auditors, the Company’s internal audit function and the Company’s compliance with its Code of Conduct;
•
annually review an independent auditor’s report describing, among other things, the auditing firm’s internal quality-control procedures, any material issues raised by the most recent internal quality control review, or peer review, of the auditing firm;
•
discuss and review the annual audited financial and quarterly statements with management and the independent auditor (including disclosures in “Management’s Discussion and Analysis of Financial Condition and Results of Operation”), review and approve financial information before submission to the SEC and monitor the Company’s Sarbanes-Oxley internal control compliance on an annual basis;
•
discuss earnings press releases, as well as financial information and earnings guidance provided to analysts and rating agencies;
•
discuss policies with respect to risk assessment and risk management;
•
meet separately, periodically, with management, the internal auditors and the independent auditor;
•
review with the independent auditors any audit problems or difficulties with management’s responses;
•
set clear hiring policies for employees or former employees of the independent auditors;
•
annually review the adequacy of the Audit Committee’s written charter;
•
prepare any report or other disclosure by the Audit Committee required to be included in any proxy statement under the rules of the SEC;
•
handle such other matters as delegated to the Audit Committee by the Board of Directors;
•
report regularly to the full Board of Directors; and
•
self-evaluate the performance of the Audit Committee.
|
8
|
|
Name of Committee and Members
|
Representative Functions of the Compensation Committee
|
Number of
Meetings in
2016
|
|
Compensation:
David H. Wasserman,
Chairman
Edward J. Mooney
Christopher D. Pappas
|
•
make recommendations to the Board as to Univar’s overall compensation philosophy and oversee the development and implementation of compensation programs;
•
establish the total compensation package provided to the Chief Executive Officer, other officers and other persons reporting directly to the Chief Executive Officer, including its subsidiaries’ executives;
•
develop and recommend to the Board compensation for Board members and recommend the amount of stock in Univar that directors should hold;
•
oversee Univar’s and its subsidiaries’ general incentive compensation plans and equity based plans;
•
help ensure the Company’s compensation policies do not encourage excessive risk taking;
•
produce a Compensation Committee report on executive compensation to be included in Univar’s annual proxy statement filed with the Securities and Exchange Commission (the “SEC”), in accordance with the applicable rules and regulations of the SEC, New York Stock Exchange and other regulatory bodies;
•
oversee compliance with any applicable compensation reporting requirements of the SEC;
•
retain consultants from time to time to advise the Committee on executive compensation policies and practices and review the independence of such consultants;
•
administer all plans that require “disinterested administration” under Rule 16b-3 the Securities Exchange Act of 1934, as amended; and
•
periodically review succession plans of the Chief Executive Officer of Univar and its subsidiaries and screen and recommend to the Board candidates for Chief Executive Officer and such other senior executive officers as may be determined by the Committee.
|
6
|
|
Name of Committee and Members
|
Representative Functions of the Nominating and Corporate Governance Committee
|
Number of
Meetings in
2016
|
|
Nominating and Corporate Governance:
William S. Stavropoulos,
Chairman
Richard P. Fox Christopher D. Pappas
|
•
develop and recommend criteria for selecting nominees for director and periodically review the criteria;
•
identify and recommend to the Board candidates qualified and suitable to become members of the Board consistent with the Company’s Board criteria;
•
identify and recommend Board members to serve on committees of the Board;
•
develop and recommend to the Board a set of Corporate Governance Principles; and
•
establish procedures for the evaluation of the Board.
|
2
|
|
•
|
the following for each recommending shareholder: (i) name and address, (ii) class and number of shares of the Company’s common stock that are beneficially owned, (iii) a representation they are a holder of record entitled to vote at such meeting and intend to appear in person or by proxy at the meeting to propose such nomination, (iv) a representation as to whether such shareholder is intending to join or be part of a group which intends to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Company’s outstanding capital stock required to elect the nominee and/or otherwise to solicit proxies from shareholders in support of such proposal or nomination, and (v) a description of any derivatives, debt or other instruments or arrangements;
|
|
•
|
the name, age, business address and principal occupation and employment of the recommended nominee;
|
|
•
|
any information relevant to a determination of whether the recommended nominee meets the criteria for Board of Directors membership established by the Board of Directors and/or the Nominating and Corporate Governance Committee;
|
|
•
|
any information regarding the recommended nominee relevant to a determination of whether the recommended nominee would be considered independent under the applicable NYSE rules;
|
|
•
|
all other information relating to the recommended nominee that is required to be disclosed in solicitations for proxies in an election of directors pursuant to Regulation 14A under the Exchange Act, including, without limitation, information regarding (1) the recommended nominee’s business experience over the past five years, (2) the class and number of the Company’s shares, if any, that are beneficially owned by the recommended nominee and (3) material relationships or transactions, if any, between the recommended nominee and the Company or management;
|
|
•
|
a description of any business or personal relationships between the recommended nominee and the recommending shareholder(s);
|
|
•
|
a statement, signed by the recommended nominee, (1) verifying the accuracy of the biographical and other information about the nominee that is submitted with the recommendation and (2) affirming the recommended nominee’s willingness to be a director and to be named in the proxy statement; and
|
|
•
|
if the recommending shareholder(s) has beneficially owned more than 1% of the Company’s voting stock for at least one year as of the date the recommendation is made, evidence of such beneficial ownership as specified in the rules and regulations of the SEC.
|
|
|
|
Year ended December 31,
|
||||||||||
|
(in millions)
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|||
|
CD&R Investor:
|
|
|
|
|
|
|
||||||
|
Sales to affiliate companies
|
|
$
|
0.5
|
|
|
$
|
1.9
|
|
|
$
|
9.1
|
|
|
Purchases from affiliate companies
|
|
-
|
|
|
$
|
8.8
|
|
|
$
|
10.2
|
|
|
|
CVC Investor
(1)
|
|
|
|
|
|
|
||||||
|
Sales to affiliate companies
|
|
$
|
7.7
|
|
|
$
|
29.7
|
|
|
$
|
20.9
|
|
|
Purchases from affiliate companies
|
|
$
|
16.5
|
|
|
$
|
19.9
|
|
|
$
|
21.6
|
|
|
Temasek Investor:
|
|
|
|
|
|
|
||||||
|
Sales to affiliate companies
|
|
$
|
14.4
|
|
|
$
|
19.8
|
|
|
-
|
|
|
|
Purchases from affiliate companies
|
|
$
|
10.1
|
|
|
$
|
0.1
|
|
|
-
|
|
|
|
|
|
|
December 31,
|
||||||
|
(in millions)
|
|
|
2016
|
|
|
2015
|
|
||
|
Due from affiliates
|
|
|
$
|
2.3
|
|
|
$
|
4.1
|
|
|
Due to affiliates
|
|
|
$
|
2.1
|
|
|
$
|
6.6
|
|
|
•
|
Board Committee Charters
. The Audit, Compensation, and Nominating and Corporate Governance Committees of the Board of Directors operate pursuant to written charters. All of the Committee charters are available on the Company’s website at www.univar.com/investors.
|
|
•
|
Corporate Governance Guidelines
. The Board of Directors has documented its corporate governance principles in the Guidelines, which were adopted to reflect certain best practices and requirements of the NYSE. The Guidelines are available on the Company’s website at www.univar.com/investors.
|
|
•
|
Code of Conduct and Code of Ethics for the Chief Executive Officer and Senior Financial Officers
. Univar’s Code of Conduct emphasizes the Company’s commitment to the
|
|
•
|
Private Executive Sessions.
The non-management members of the Board of Directors conduct executive session meetings during the majority of their quarterly meetings in which no member of management is present to discuss any matter selected by a member. Further, the Company’s independent directors conduct meetings periodically as required by SEC standards and the Company’s Corporate Governance Guidelines.
|
|
•
|
Advance Materials.
Information and data important to the directors’ understanding of the business or matters to be considered at a Board or Board Committee meeting are, to the extent practical, distributed to the directors sufficiently in advance of the meeting to allow careful review prior to the meeting.
|
|
•
|
Board and Committees Self-Evaluations.
The Board has an annual self-evaluation process, which is completed by each member of the Board. This assessment focuses on the Board’s contribution to the Company and the Board’s process and procedures. In addition, the Audit, Compensation and Nominating and Corporate Governance Committees also conduct a similar annual self-evaluation, each of which are reviewed by the relevant Committee Chairman. The results of Board evaluations are reviewed by the Nominating and Corporate Governance Committee and the Board may take action based on noted weaknesses.
|
|
•
|
Access to Management and Employees.
Directors have full and unrestricted access to the management and employees of the Company. Additionally, key members of management attend Board meetings to present information about the results, plans and operations of the business within their areas of responsibility.
|
|
•
|
Access to Outside Advisers.
The Board and its Committees may retain counsel or consultants without obtaining the approval of any officer of the Company in advance or otherwise. The Audit Committee has the sole authority to retain and terminate the independent auditor. The Nominating and Corporate Governance Committee has the authority to retain search firms to be used to identify director candidates. The Compensation Committee has the authority to retain compensation consultants for advice on executive compensation matters.
|
|
•
|
Mr. Daniel P. Doheny;
|
|
•
|
Mr. Edward J. Mooney;
|
|
•
|
Ms. Juliet Teo; and
|
|
•
|
Mr. David H. Wasserman.
|
|
Mr. Daniel P. Doheny
|
|
|
Director of Univar since: 2016
Committees Served: Audit
|
Since 2000, Mr. Doheny, age 54, has been with Reyes Holdings, LLC, the 12th largest privately held company in the United States. Since 2014, he has served as Chairman of Reyes’ Great Lakes Coca-Cola Distribution business and has successfully led the company’s acquisitions and integration of the distribution of Coca-Cola products. From 2000 to 2014, Mr. Doheny served as Chief Financial Officer and was responsible for all financial aspects of the business, including acquisitions, financing, internal controls and reporting, capital investments, and budgeting. He also played a key role in strategy development, information technology and human resources. Prior to joining Reyes, Mr. Doheny spent more than 16 years with KPMG LLP in Chicago, Ill., and Montvale, N.J., including six years as an audit partner. He was the founder of the KPMG Audit Committee Institute, advising public boards of directors around the world. Mr. Doheny currently serves on the board of directors of the Special Olympics of Illinois Foundation. Mr. Doheny holds a bachelor’s degree in accountancy from the University of Illinois and is a certified public accountant.
Qualifications:
Mr. Doheny's executive and board experience in distribution provides him with valuable leadership and distributor industry knowledge. Mr. Doheny's extensive experience and knowledge in finance and accounting, and his experience leading a finance function qualifies him to serve on the Board and its audit committee.
|
|
|
|
|
Mr. Edward J. Mooney
|
|
Director of Univar since: 2016
Committees Served: Compensation
|
From March 2000 to March 2001, Mr. Mooney, age 75, served as a Délégué General-North America, Suez Lyonnaise des Eaux. From 1969 to 2000, he held numerous executive position at Nalco Chemical Company, including President and Chief Operating Officer, before becoming Chairman and Chief Executive Officer in 1994. He previously served on the boards of Cabot Microelectronics Corporation, Commonwealth Edison Company (a subsidiary of Exelon Corporation), FMC Corp., the Northern Trust Corporation, and PolyOne Corp. He holds a B.S in chemical engineering and J.D from the University of Texas. Mr. Mooney is a graduate of the MIT Sloan Senior Executive Program.
Qualifications:
Mr. Mooney's extensive experience in the chemical industry is of great value to the Company. His deep public company board and managerial experience are a great asset for the Board and the governance of the Company.
|
|
|
|
|
Ms. Juliet Teo
|
|
Director of Univar since: 2015
Committees Served: none
|
Since April 1996, Ms. Teo, age 47, has been with Temasek Holding (Private) Limited ("Temasek"), a global investment company based in Singapore. She is currently Senior Managing Director, Investment, with primary responsibility for transport and logistics investments. During her 19-year tenure at Temasek, Ms. Teo has been involved in originating, evaluating, and managing investment opportunities across a broad range of sectors, including financial services, telecommunications, media & technology, and transport and logistics. She has also been involved in shaping various institutional initiatives within Temasek, including organizational structures, talent development and governance framework. Prior to joining Temasek, Ms. Teo was with Singapore Press Holdings. She received a bachelor’s degree in business administration from the National University of Singapore and is a CFA charter holder.
Qualifications
: Ms. Teo has deep experience in acquisitions, financing and capital transactions in many industries. She brings to the Company a broad understanding of operational and financial issues faced by businesses like the Company; and, among other things, she offers keen insights on the Company’s business development and acquisition activities.
|
|
|
|
|
Mr. David H. Wasserman
|
|
Director of Univar since: 2010
Committees Served: Compensation (Chair)
|
Since 1998, Mr. Wasserman, age 50, has been with Clayton, Dubilier & Rice, LLC ("CD&R"), a global private equity firm. Before joining CD&R, he worked in the principal investment area at Goldman, Sachs & Co., an investment banking and securities firm, and as a management consultant at Monitor Company, a strategy consulting firm. Mr. Wasserman led CD&R’s acquisition of Hertz from Ford Motor Company, the carve-out of Culligan Ltd. from Veolia Environment and the acquisition of ServiceMaster Global Holdings, Inc. He currently serves as a director at SiteOne Landscape Supply, Solenis and Tranzact. Mr. Wasserman previously served on the boards of Kinko’s, Inc., Covansys Corporation, Culligan, Hertz, ServiceMaster and ICO Global Communications (Holdings) Limited, currently known as Pendrell Corporation. He is a graduate of Amherst College and holds an MBA from Harvard Business School.
Qualifications
: Mr. Wasserman brings to the Company extensive knowledge of the capital markets, experience as a management consultant and experience as a director of other chemicals, services and distribution businesses. In addition to having broad knowledge of the types of operational, compensation and management issues faced by the Company, his service on other boards permits him to assist the Company with its governance and activities as a public company.
|
|
|
|
|
Mr. Mark J. Byrne
|
|
Director of Univar since: 2014
Committees Served: none
|
Mr. Byrne, age 60, joined Univar in December 2010 and serves as a member of the Board. He was formerly a consultant to the Company. He served as the Chairman of Commodities from February 2014 through January 2015. From February 2013 to January 2014, he was the Executive Chairman of Univar Basic Chemical Solutions (BCS). From December 2010 to September 2011, he served as Chief Operating Officer of Univar. Prior to Univar, Mr. Byrne served as the President and Chief Executive Officer of BCS, a company he co-founded in 1995. Under Mr. Byrne’s leadership, BCS grew to become a company with global operations and nearly $900 million in 2009 sales revenue. Prior to BCS, Mr. Byrne began his career in 1980 at AlliedSignal (now Honeywell) where he held roles in several functional areas, culminating as President of AlliedSignal’s Fluorine Products Division. Mr. Byrne currently serves on the board of managers of V Global Holdings LLC. Mr. Byrne holds a Bachelor of Science in economics and finance and Masters in Business Administration from Fairleigh Dickinson University.
Qualifications:
Mr. Byrne has broad managerial and operational experience in chemical distribution and basic chemicals markets - Univar’s principal areas of business. He also brings to the Board his deep experience with BCS, which was acquired by the Company in 2010.
|
|
|
|
|
Mr. William S. Stavropoulos
|
|
Director of Univar since: 2010
Committees Served: Nominating and Corporate Governance (Chair)
Lead Director
|
Mr. Stavropoulos, age 77, has been the Lead Director since November 2016. He previously served as Univar's non-executive chairman from November 2010 to November 2016. From May to December 2012, he served as Univar's Lead Director. Since 2006, he has been an Advisory Partner to Clayton, Dubilier & Rice, a global private equity firm. Mr. Stavropoulos is currently Chairman Emeritus of the board of directors of The Dow Chemical Company, a diversified chemical company. From 2000 to 2006, he served as Chairman of Dow; from 2002 to 2004 he was Chairman and Chief Executive Officer; from 1995 to 2000 he was President and Chief Executive Officer; and from 1993 to 1995, he was President and Chief Operating Officer. In a career spanning 39 years at Dow, Mr. Stavropoulos also served in a variety of positions in research, marketing and general management and was a member of the board of directors of Dow from July 1990 to March 2006. He is a director of Teradata Corporation, Maersk Inc., and Tyco International, Inc., and is on the Advisory Board for Metalmark Capital LLC. He is a trustee to the Fidelity Group of Funds. Mr. Stavropoulos is the President and Founder of the Michigan Baseball Foundation. Mr. Stavropoulos is past Chairman of the American Chemistry Council, Society of Chemical Industry, and American Plastics Council. He earned a B.S. degree from Fordham University and a doctorate in medicinal chemistry from the University of Washington.
Qualifications
: Mr. Stavropoulos’ tenure as an executive officer and chief executive officer at a leading chemical company allows him to bring an enormous wealth of experience on all matters impacting the Company: strategic, management, operational, functional and financial. His service on multiple public company boards also permits him to contribute to Univar’s governance and the functioning of its Board and Committees.
|
|
|
|
|
Mr. Robert L. Wood
|
|
Director of Univar since: 2016
Committees Served: Audit
|
From 2004 to 2008, Mr. Wood, age 62, was Chairman, President and CEO of Chemtura, a global specialty chemicals company listed on the New York Stock Exchange and Euronext Paris. He spent 27 years in a variety of sales, marketing and management roles within the Dow Chemical organization and ultimately became the Business Group President of the Thermosets and Dow Automotive Group. In this role, Mr. Wood was named to Dow's Corporate Operating Board, which was charged with setting corporate strategy and establishing corporate policies. Prior to that, Mr. Wood was the Global Vice President of Polyurethanes and Global Vice President of Engineered Plastics. Mr. Wood currently serves on the board of Praxair and MRC Global Inc. He previously served on the board of the Jarden Corporation. He is currently the Chairman of the United States Gymnastics Foundation and has recently been added to the U.S. Olympic Committee's board of directors. He holds a bachelor's degree from the University of Michigan.
Qualifications:
Mr. Wood's deep experience in the chemical industry and his managerial experience is valuable for all aspects of the operations of the Company. His role as a director of other public companies provides valuable corporate governance insight the Board.
|
|
|
|
|
Mr. Richard P. Fox
|
|
Director of Univar since: 2007
Committees Served: Audit (Chair);
Nominating and Corporate Governance
|
Since 2001, Mr. Fox, age 69, has served as a consultant and outside board member to companies in varying industries. From 2000 to 2001, he was President and Chief Operating Officer of CyberSafe Corporation, a provider of e-security solutions and services. Prior to joining CyberSafe, Mr. Fox was Chief Financial Officer and a member of the board of directors of Wall Data, Incorporated, a software company. Mr. Fox spent 28 years at Ernst & Young LLP, last serving as Managing Partner of its Seattle office. He serves on the boards of directors of Acxiom Corporation, ServiceMaster, and Pinnacle West Capital Corporation. In addition, he serves as a member of the board of directors of HonorHealth and Premera Blue Cross and is on the board of visitors of the Fuqua School of Business at Duke University. Mr. Fox previously served on the boards of Pendrell Corporation, Orbitz Worldwide, aQuantive Inc., Shurgard Storage Centers Inc., PopCap Games and Flow International. Mr. Fox received a B.A. degree in business administration from Ohio University and an MBA from the Fuqua School of Business at Duke University. He is a certified public accountant.
Qualifications
: As a result of his extensive accounting and financial management experience, Mr. Fox has a deep understanding of financial reporting processes, internal accounting and financial controls, independent auditor engagements, and other audit committee and board functions. Mr. Fox’s financial, accounting and management expertise, along with his experience on other boards, qualify him to serve on the Board.
|
|
|
|
|
Mr. Stephen D. Newlin
|
|
Director of Univar since: 2014
Committees Served: none
|
Mr. Newlin, age 64, has served as President and Chief Executive Officer of Univar since June 2016. In November 2016, he was appointed Chairman of the Board. He previously served as Chairman, President and Chief Executive Officer of PolyOne Corporation from 2006-2014, and Executive Chairman of the Board until 2016. From 2003 to 2006, Mr. Newlin was President, Industrial Sector at Ecolab, Inc. He previously spent 24 years at Nalco Chemical Company in positions of increasing responsibility, and served as President and Director of Nalco from 1998 to 2001, and was President, Chief Operating Officer, and Vice Chairman from 2000 to 2001. In addition to his election to the Univar Board of Directors in 2014, Mr. Newlin currently serves on the boards of directors of The Chemours Company and Oshkosh Corporation. Mr. Newlin holds a bachelor’s degree in civil engineering from the South Dakota School of Mines & Technology, and has completed the Tuck Executive Program at Dartmouth College and the Harvard Business School’s Advanced Management Program. He also served as a commissioned officer in the U.S. Public Health Service, earning an accelerated promotion.
Qualifications
: Mr. Newlin’s extensive experience as an executive and chief executive of multinational companies permits him to bring to the Company a deep insight of the management of all elements of a global business. His service on other public company boards and his keen understanding of international business and regulatory issues is also a great asset for Univar.
|
|
|
|
|
Mr. Christopher D. Pappas
|
|
Director of Univar since: 2015
Committees Served: Compensation;
Nominating and Corporate Governance
|
Mr. Pappas, age 61, has served since 2010 as President and Chief Executive Officer of Trinseo, a leading global materials company. From 2000 to 2009, he was an executive at NOVA Chemicals Corporation, a developer and manufacturer of chemicals, plastic resins, and end-products, where he assumed executive roles with increasingly global responsibilities, including President and Chief Executive Officer from May 2009 to November 2009. Mr. Pappas also serves on the board of directors for Trinseo S.A. and FirstEnergy Corporation, a diversified energy company dedicated to safety, reliability and operational excellence. Previously, he served on the boards of directors for Methanex Corp., NOVA Chemicals Corporation, and Allegheny Energy, Inc. Mr. Pappas holds a bachelor’s degree in civil engineering from The Georgia Institute of Technology and a M.B.A. from The Wharton School of Business at The University of Pennsylvania.
Qualifications
: Mr. Pappas’s executive and board experience has equipped him with leadership skills and the knowledge of board processes and functions. Additionally, Mr. Pappas’s general corporate decision-making and senior executive experience with a commodity-based business provides a useful background for understanding the operations of Univar.
|
|
|
|
|
Mr. Stephen W. Shapiro
|
|
Director of Univar since: 2016
Committees Served: none
|
Mr. Shapiro, age 39, is a partner for Clayton, Dubilier, & Rice, LLC ("CD&R"), a global private equity firm he joined in 2002. Prior to CD&R, Mr. Shapiro worked in the investment banking division of Merrill Lynch & Co. and at Perry Capital, a multi-strategy investment firm. He also serves as a Director of Solenis, Tranzact and TruGreen. Mr. Shapiro earned a B.S. from Duke University and a M.B.A. from Stanford University.
Qualifications:
Mr. Shapiro's knowledge of the capital markets, experience in investment banking and as a director of other major chemical, service and supply chain businesses qualifies him to serve on the Board. His deep experience in mergers and acquisitions are valuable in guiding the Company's merger and acquisition activities.
|
|
|
|
2016
(in millions)
|
|
2015
(in millions)
|
||||
|
Audit fees
(1)
|
|
$
|
4,985,000
|
|
|
$
|
2,845,000
|
|
|
Audit-related fees
(2)
|
|
$
|
380,790
|
|
|
$
|
375,000
|
|
|
Audit and audit-related fees
|
|
$
|
5,365,790
|
|
|
$
|
3,220,000
|
|
|
Tax fees
|
|
—
|
|
|
—
|
|
||
|
All other fees
|
|
—
|
|
|
—
|
|
||
|
Total fees
|
|
$
|
5,365,790
|
|
|
$
|
3,220,000
|
|
|
(1)
|
Audit fees for 2016 and 2015 include fees for the audit of the annual consolidated financial statements, reviews of the condensed consolidated financial statements included in the Company’s quarterly reports. The 2016 fees also include the first time assessment of internal controls over financial reporting.
|
|
(2)
|
Audit-related fees for 2016 include fees for multiple S-3 filings. Audit-related fees for 2015 included fees for the initial public offering and debt offering of $400 million of unsecured notes.
|
|
•
|
Each of the entities which have reported to the Securities and Exchange Commission (“SEC”) or have advised the Company that they are a “beneficial owner,” as defined by the SEC’s rules and regulations, of more than 5% of the Company’s outstanding Common Stock;
|
|
•
|
Each member of the Board of Directors and each nominee;
|
|
•
|
Each of the Company’s named executive officers in the section titled Executive Compensation; and
|
|
•
|
All members of the Board of Directors and the Company’s executive officers as a group.
|
|
Name of Beneficial Owner
|
|
Shares of
Common Stock Owned (1) |
|
|
Percent
|
|
|
CD&R Univar Holdings, L.P. and related funds
(2)
|
|
21,561,039
|
|
|
15.40
|
%
|
|
Dahlia Investments Pte. Ltd. and related funds
(3)
|
|
14,171,599
|
|
|
10.12
|
%
|
|
FMR LLC
(4)
|
|
17,038,398
|
|
|
12.17
|
%
|
|
Longview Asset Management, LLC
(5)
|
|
9,185,917
|
|
|
6.56
|
%
|
|
Mark J. Byrne
(6)(7)(8)
|
|
306,890
|
|
|
*
|
|
|
Daniel P. Doheny
(7)
|
|
10,707
|
|
|
*
|
|
|
Richard P. Fox
(7)
|
|
10,542
|
|
|
*
|
|
|
J. Erik Fyrwald
(9)
|
|
861,491
|
|
|
*
|
|
|
Michael J. Hildebrand
(6)
|
|
116,669
|
|
|
*
|
|
|
David C. Jukes
(6)(11)
|
|
159,434
|
|
|
*
|
|
|
Stephen N. Landsman
(6)
|
|
246,931
|
|
|
*
|
|
|
Carl J. Lukach
(6)
|
|
125,943
|
|
|
*
|
|
|
Edward J. Mooney
(12)
|
|
10,962
|
|
|
*
|
|
|
Stephen D. Newlin
(7)(10)
|
|
314,942
|
|
|
*
|
|
|
Christopher Oversby
(13)
|
|
86,590
|
|
|
*
|
|
|
Christopher D. Pappas
(7)
|
|
55,088
|
|
|
*
|
|
|
Stephen W. Shapiro
|
|
0
|
|
|
*
|
|
|
William S. Stavropoulos
(7)
|
|
10,542
|
|
|
*
|
|
|
Juliet Teo
|
|
0
|
|
|
*
|
|
|
David H. Wasserman
|
|
0
|
|
|
*
|
|
|
Robert L. Wood
(12)
|
|
7,462
|
|
|
*
|
|
|
All directors and executive officers as a group (21 persons)
(14)
|
|
2,545,430
|
|
|
1.82
|
%
|
|
*
Share ownership does not exceed one percent.
|
|
|
|
|
||
|
(1)
|
Represents following for each beneficial owner: (i) shares of common stock held, (ii) Restricted Stock Units ("RSUs") that will vest within 60 days of March 8, 2017, and (iii) options exercisable within 60 days of March 8, 2017.
|
|
(2)
|
This information is based solely on Amendment No. 3 to the Schedule 13D filed jointly on February 3, 2017 by CD&R Univar Holdings, L.P., CD&R Associates VIII, Ltd., CD&R Associates VIII, L.P., and CD&R Investment Associates VIII, Ltd. (“CD&R Holdings”). The Amendment No. 3 to the Schedule 13D indicates that as of February 3, 2017, CD&R Holdings was the beneficial owner with shared voting power as to 21,561,039 shares and shared dispositive power as to 21,561,039 shares. CD&R Associates VIII, Ltd., as the general partner of CD&R Holdings, CD&R Associates VIII, L.P., as the sole stockholder of CD&R Associates VIII, Ltd., and CD&R Investment Associates VIII, Ltd., as the general partner of CD&R Associates VIII, L.P., may each be deemed to beneficially own the shares held by CD&R Univar Holdings, L.P. CD&R Investment Associates VIII, Ltd. is managed by a two-person board of directors. Donald J. Gogel and Kevin J. Conway, as directors of CD&R Investment Associates VIII, Ltd., may be deemed to share beneficial ownership of the shares of the shares held by CD&R Holdings. Such persons expressly disclaim such beneficial ownership. Investment and voting decisions with respect to such shares are made by an investment committee of limited partners of CD&R Associates VIII, L.P., currently consisting of more than ten individuals, or the Investment Committee. All members of the Investment Committee expressly disclaim beneficial ownership of the shares held by CD&R Holdings. Each of CD&R Associates VIII, Ltd., CD&R Associates VIII, L.P. and CD&R Investment Associates VIII, Ltd. expressly disclaims beneficial ownership of the shares held by CD&R Holdings. The address for each of CD&R Holdings, CD&R Associates VIII, Ltd., CD&R Associates VIII, L.P. and CD&R Investment Associates VIII, Ltd. is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.
|
|
(3)
|
This information is based solely on Amendment No. 2 to the Schedule13D filed jointly with the SEC on February 6, 2017 by Temasek Holdings (Private) Limited, Tembusu Capital Pte. Ltd., Thomson Capital Pte. Ltd., and Dahlia Investments Pte. Ltd. (collectively “Dahlia”). The Amendment No. 2 to the Schedule 13D indicates that as of February 3, 2017, Dahlia was the beneficial owner with shared voting power as to 14,171,599 shares and shared dispositive power as to 14,171,599 shares. Does include 5,996 restricted shares issued to Dahlia, as assignee of compensation
|
|
(4)
|
This information is based solely on the Schedule 13G filed with the SEC on January 10, 2017 by FMR LLC and Abigail Johnson. Abigail P. Johnson is a Director, the Vice Chairman, the Chief Executive Officer and the President of FMR LLC. The securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC and certain of its subsidiaries and affiliates are reflected in the table above. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act ("Fidelity Funds") advised by Fidelity Management & Research Company ("FMR Co"), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds' Boards of Trustees. Fidelity Management & Research Company carries out the voting of the shares under written guidelines established by the Fidelity Funds' Boards of Trustees. The address for each of FMR LLC and Ms. Johnson is 245 Summer Street, Boston, MA 02210.
|
|
(5)
|
This information is based solely on Amendment No.1 of the Schedule 13G filed with the SEC on February 10, 2017 by Longview Asset Management, LLC ("Longview"). Longview reported that as of December 31, 2016, they have shared voting power as to 9,185,917 shares, and shared dispositive power as to 9,185,917 shares. Longview's address is 222 N. LaSalle Street, Suite 2000, Chicago, Illinois 60601.
|
|
(6)
|
Includes stock options exercisable within 60 days from
March 8, 2017
: (i) Mr. Byrne 251,953, (ii) Mr. Hildebrand 111,439, (iii) Mr. Jukes 128,103, (iv) Mr. Landsman 182,353, and (v) Mr. Lukach 62,988.
|
|
(7)
|
Includes restricted shares granted to the directors for board service that are scheduled to vest on May 4, 2017 as follows: Mr. Byrne, 5,996 shares; Mr. Doheny, 10,707 shares; Mr. Fox, 5,996 shares; Mr. Newlin, 5,996 shares, Mr. Pappas, 5,996 shares; Mr. Stavropoulos, 5,996 shares.
|
|
(8)
|
The common stock is owned by Cypress Forest Capital LLC. Mr. Byrne is a manager of Cypress Forest Capital LLC (“CFC”), which is majority owned by The Mark and Barbara Byrne Revocable Living Trust created UTA dated September 24, 2002, as amended (the “BRT”). BRT is a trust established by Mr. Byrne and his wife. Mr. Byrne is both a trustee and a beneficiary. The remaining equity interest in CFC is owned by The Byrne Family Irrevocable Children’s Trusts (“BFTs”) for the benefit of Mr. Byrne’s children. Mr. Byrne is neither a trustee nor a beneficiary of the BFTs and disclaims beneficial ownership in the proportional interest of Univar shares owned indirectly by the BFTs.
|
|
(9)
|
Mr. Fyrwald served as Univar’s President and Chief Executive Officer. Beneficial ownership information for the number of shares owned for Mr. Fyrwald is based on information contained in the last filed Form 4 with respect to Univar. This number includes (i) 20,000 shares owned by his wife, for which he disclaims beneficial ownership, and (ii) 715,514 shares held in family trusts. Mr. Fyrwald does not have any outstanding and exercisable stock options as of March 8, 2017.
|
|
(10)
|
Includes for Mr. Newlin 66,668 RSUs and 37,500 options that are scheduled to vest within 60 days from
March 8, 2017
, and includes 28,892 shares held in trust. 114,583 RSUs are excluded, but could vest within sixty days of March 8, 2017 if Univar's share price closes over $30 for twenty consecutive trading days.
|
|
(11)
|
Includes for Mr. Jukes 6,299 restricted shares.
|
|
(12)
|
Includes for Messrs. Mooney and Wood prorated awards of 7,462 restricted shares each as new directors awarded on November 7, 2016.
|
|
(13)
|
Mr. Oversby served as Univar’s President EMEA. Beneficial ownership information for the number of shares owned for Mr. Oversby is based on information contained in the last filed Form 4 with respect to Univar. This number includes 45 shares, 40 shares, 39 shares, and 41 shares respectively owned by his sons George, Matthew, Neil and Nicholas, for which he disclaims beneficial ownership. Mr. Oversby does not have any outstanding and exercisable stock options as of March 8, 2017.
|
|
(14)
|
Includes the following for the directors and executive officers: (i) stock options exercisable within 60 days from
March 8, 2017
in the amount of 1,009,267, and (ii) 188,668 RSUs that are scheduled to vest within 60 days from
March 8, 2017
.
|
|
Name
|
Age
|
Office
|
Positions Held Since January 1, 2012
|
|
Stephen D. Newlin
|
64
|
Chairman, President and Chief Executive Officer
|
June 2016 to present served as President and Chief Executive Officer, and Chairman of the Board since November 2016. Prior to Univar, Chairman, President and Chief Executive Officer of PolyOne Corporation from 2006-2014, and Executive Chairman of the Board until 2016. From 2003 to 2006, Mr. Newlin was President, Industrial Sector at Ecolab, Inc. Prior to Ecolab, Mr. Newlin spent 24 years at Nalco Chemical Company in positions of increasing responsibility, and served as President and Director of Nalco from 1998 to 2001, and was President, Chief Operating Officer, and Vice Chairman from 2000 to 2001.
|
|
Carl J. Lukach
|
61
|
Executive Vice President,
Chief Financial Officer
|
December 2014 to present served as Executive Vice President, Chief Financial Officer of Univar. Prior to Univar, a 34-year career at DuPont. Most recently served as Vice President of Treasury, Tax and Investor Relations for DuPont’s Performance Chemicals Company. Prior to that held numerous finance and business leadership positions, including Vice President of Investor Relations, and President of DuPont East Asia.
|
|
Michael J. Hildebrand
|
51
|
President, Canada and Global
Agriculture and Environmental Sciences
|
October 2014 to present served as President of Canada, Global Agriculture and Environmental Sciences (AGES) for Univar. January 2013 to October 2014 served as Vice President Global Agriculture & Environmental Sciences for Univar. December 2010 to January 2013, Vice President of Human Resources for Univar Canada.
|
|
David C. Jukes
|
57
|
Executive Vice President, President Univar USA and LATAM
|
June 2016 to present served as Executive Vice President and President of Univar USA , and President of Latin America (LATAM) since September 2015. From 2011 to 2016, Mr. Jukes served as President of Univar EMEA. From July 2009 to January 2011 he served as Vice President, Sales and Marketing EMEA, and from April 2004 to June 2009 as Regional Director of Univar UK, Ireland, the Nordics and Distrupol.
|
|
Stephen N. Landsman
|
57
|
Executive Vice President,
General Counsel and Secretary
|
June 2013 to present served as Executive Vice President, General Counsel and Secretary of Univar. 2003–2013 served as Vice President, General Counsel, and Corporate Secretary of Nalco Holding Company.
|
|
Dr. Manian Ramesh
|
59
|
Executive Vice President,
Business Development
|
March 2014 to present served as Executive Vice President Business Development. December 2011 to February 2013 served as Chief Technology Officer for Water and Energy Services at Ecolab Inc. 2007 to 2011 served as Chief Technology Officer of Nalco Holding Company.
|
|
George J. Fuller
|
53
|
Senior Vice President, Local Chemical Distribution, USA
|
January 2017 to present served Senior Vice President, Local Chemical Distribution, USA, from April 2015 to January 2017, Mr. Fuller served as Executive Vice President, Global Sourcing and Basic Chemicals. March 2013 to April 2015 served Senior Vice President; President-Basic Chemical Solutions of Univar. November 2012 to February 2013, served as Executive Vice President, Hydrite Chemical Co., a leading provider of chemicals and related services in North America. From 2010 to 2012 served as Vice President of Sales and Procurement at Hydrite.
|
|
Nick Powell
|
50
|
President, EMEA & APAC
|
January 2017 to present served as President, Europe, the Middle East, and Africa (EMEA) and Asia Pacific (APAC). Prior to that, Mr. Powell joined Univar in 2009, establishing Univar's Middle East and Africa business. In 2014, Mr. Powell assumed leadership of EMEA's Focused Industries, and in late 2015 assumed leadership of APAC operations.
|
|
Eric W. Foster
|
45
|
Senior Vice President,
Chief Information Officer
|
December 2016 to present served as Senior Vice President, Chief Information Officer. Prior to Univar, Senior Vice President and Chief information Officer of Baxalta Inc. from July 2015 to July 2016. Prior to that, Vice President IT of Baxter International from September 2006 to June 2015.
|
|
•
|
Stephen D. Newlin, Chairman, President and Chief Executive Officer (beginning May 31, 2016)
|
|
•
|
J. Erik Fyrwald, Former President and Chief Executive Officer (until May 31, 2016)
|
|
•
|
Carl J. Lukach, Executive Vice President and Chief Financial Officer
|
|
•
|
David C. Jukes, Executive Vice President, President Univar USA and LATAM
|
|
•
|
Michael J. Hildebrand, President, Canada and Global Agriculture and Environmental Sciences
|
|
•
|
Stephen N. Landsman, Executive Vice President, General Counsel and Secretary
|
|
•
|
Christopher Oversby, Former President, Univar Europe, Middle East and Africa (EMEA) (until December 31, 2016)
|
|
Measure
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|
|||
|
Adjusted EBITDA*
|
|
$
|
562.7
|
|
|
$
|
600.1
|
|
|
$
|
641.7
|
|
|
|
Net (Loss) Income**
|
|
$
|
(68.4
|
)
|
|
$
|
16.5
|
|
|
$
|
(20.1
|
)
|
|
|
Net Cash Provided from Operating Activities
|
|
$
|
449.6
|
|
|
$
|
356.0
|
|
|
$
|
126.3
|
|
|
|
*
**
|
Does not reflect currency adjustments.
Includes non-cash charges of $252 million in 2016.
|
|
•
|
enable the Company to attract and retain top senior leadership;
|
|
•
|
ensure that senior leaders are invested in the Company so they are aligned with shareholders and share in their success;
|
|
•
|
establish market competitive compensation plans and programs to reward senior leaders at the relative compensation level that approximates the 50th percentile for target performance when compared to other companies in its peer group, general industry and revenue range,
|
|
•
|
strategically align business and functional units within the Company and pay for performance by rewarding senior leaders, management and employees for driving profitable growth, managing working capital and generating healthy cash flows, all while avoiding unreasonable risks.
|
|
•
|
reviews and approves compensation related performance goals and other objectives of the CEO and recommends CEO compensation elements;
|
|
•
|
reviews and approves the compensation of the Company’s CEO and other senior officers and individuals reporting to the CEO;
|
|
•
|
reviews and consults with the CEO on selection of officers and evaluation of executive performance and other matters;
|
|
•
|
develops and approves compensation for non-employee directors;
|
|
•
|
reviews and establishes the peer group companies used as a reference to benchmark company performance and executive officer compensation;
|
|
•
|
oversees compliance with SEC guidelines and reviews and approves executive compensation policies, such as share ownership requirements and clawback policy;
|
|
•
|
references tally sheets, which provide a comprehensive overview of the compensation and benefits for executive officers;
|
|
•
|
sets the specific performance targets for incentive awards to govern the compensation paid to the Company’s senior officers; and
|
|
•
|
retains independent consultants to advise the Committee and confirms with the consultant that total compensation paid to each executive officer is appropriate.
|
|
•
|
U.S. based;
|
|
•
|
industry profile (distribution and chemical/gas businesses);
|
|
•
|
comparative revenue and profitability (EBITDA);
|
|
•
|
similar distribution, product offerings and capabilities; and
|
|
•
|
availability of publicly disclosed information.
|
|
|
|
|
|
|
|
Genuine Parts Co.
|
|
W. W. Grainger, Inc.
|
|
HD Supply Holdings, Inc.
|
|
WESCO International, Inc.
|
|
Ashland Inc.
|
|
FMC Corp.
|
|
MRC Global, Inc.
|
|
Celanese Corp.
|
|
PolyOne Corp.
|
|
Watsco, Inc.
|
|
Airgas, Inc.
|
|
W.R. Grace & Co.
|
|
Huntsman Corp.
|
|
Axiall Corp.
|
|
Stepan Co.
|
|
The Sherwin-Williams Co.
|
|
The Valspar Corp.
|
|
RPM International, Inc.
|
|
|
|
|
|
Position
|
|
Multiple of Base Pay
|
|
Chief Executive Officer
|
|
5X
|
|
President U.S. Business, Chief Financial Officer & General Counsel
|
|
3X
|
|
Other Senior Executives
|
|
2X
|
|
•
|
restricted shares, performance shares or restricted stock units even while unvested; and
|
|
•
|
vested stock options (Black-Scholes value)
|
|
|
|
|
|
|
|
Pay Component
|
|
Objective of Pay Component
|
|
Key Measure
|
|
|
|
|
|
|
|
Base Salary
|
|
• Provide competitive pay while managing fixed costs
• Attract and retain executives
|
|
• Individual performance
• Market pay rates
• Skills and expertise
|
|
|
|
|
||
|
Annual Cash
Incentives
|
|
• Focus on annual operating plan financial objectives
• Align and drive the Company’s strategic objectives
|
|
• Corporate and business unit Compensation Adjusted EBITDA-related goals and relative earnings performance
• Corporate and business unit working capital and free cash flow
• Individual objectives and performance
|
|
|
|
|
||
|
Equity Awards
|
|
• Value derived depends on future stock price
• Restricted stock units (RSUs) are granted to align interests of our NEOs with those of our shareholders
• Restricted stock has been granted in the past to reward and retain key talent
• Stock options have been awarded in the past to executives to align them with shareholders’ focus on value creation
• Create “ownership culture”
|
|
• Growth in stock value
• Equity ownership and alignment with shareholders
• Retention of executives
|
|
|
|
|
|
|
|
Benefits
|
|
• Benefits provide a safety net of protection in the case of illness, disability, death or retirement
• Generally, executives participate in employee benefit plans on the same basis as nonunion, salaried employees
• There are limited, additional benefits available to specific executives (e.g. non-qualified deferred compensation plans, executive physicals, financial planning, certain travel and housing costs and tax payments)
|
|
• Health and wellness of executives
• Permit executives to allocate more time for continued focus on Univar's business
|
|
•
|
Corporate or Business Unit Compensation Adjusted EBITDA
—For purposes of calculating payouts under the MIP, Compensation Adjusted EBITDA is calculated as Adjusted EBITDA* assessed on the basis of budgeted exchange rates to neutralize the effect of currency fluctuations, adjusting for any variance in corporate cost allocations and excluding the impact of any unbudgeted acquisitions.
|
|
•
|
Corporate or Business Unit Average Working Capital
—For purposes of calculating payouts under the MIP, average working capital is calculated by dividing a 13 point straight average of month-end working capital (December of the preceding year through December of the covered year) by the last twelve months of external net sales. This number is then also adjusted for exchange rate effects by bringing the results back to currency neutral.
|
|
•
|
Corporate Free Cash Flow
—For purposes of calculating payouts under the MIP, free cash flow is calculated by adding together net cash provided by operating activities and net cash used by investing activities, exclusive of cash paid for acquisitions (both as they appear in the Company’s audited consolidated financial statements included in the Company's Form 10-K filed with the SEC on February 28, 2017).
|
|
|
|
Incentive Funding Weighting
|
|
|||||
|
Executive
|
Aggregate
Individual
Target
|
Corporate
Compensation
Adjusted
EBITDA
|
Corporate
Average
Working
Capital
|
Corporate
Free Cash
Flow
|
Business Unit
Compensation
Adjusted
EBITDA
|
Business Unit
Average
Working
Capital
|
Management Development and Succession Goals
|
Business Unit
Payout Allocation:
|
|
Stephen D. Newlin
|
$1.5 million
|
35%
|
10%
|
5%
|
|
|
50%
|
Corporate
results
against target
|
|
Carl J. Lukach
|
80% of
base salary
|
70%
|
20%
|
10%
|
|
|
|
Corporate results
against target
|
|
David C. Jukes
|
80% of
base salary
|
25%
|
|
|
50%
|
25%
|
|
EMEA and U .S. results
against target
|
|
Michael J. Hildebrand
|
70% of
base salary
|
25%
|
|
|
50%
|
25%
|
|
Canada results
against target
|
|
Stephen N. Landsman
|
80% of
base salary
|
70%
|
30%
|
|
|
|
|
Corporate results
against target
|
|
Christopher Oversby
|
65% of base salary
|
25%
|
|
|
50%
|
25%
|
|
U.S. and EMEA results against target
|
|
|
|
|
|
|
|
|
|
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
|
|
|
|
|||
|
Compensation MIP Metric
|
|
Performance % Target /
Payout % Target
|
|
Performance %
Target /
Payout % Target
|
|
Performance %
Target /
Payout % Target
|
|
|
|
|
|
|||
|
Corporate Compensation Adjusted EBITDA
|
|
93% target earned
25% Payout
|
|
100% target earned
100% Payout
|
|
110% target earned
200% Payout
|
|
|
|
|
|
|
|
|
|
U.S. Compensation Adjusted EBITDA
|
|
94% target earned
25% Payout
|
|
100% target earned
100% Payout
|
|
110% target earned
200% Payout
|
|
|
|
|
|
|||
|
Canada Compensation Adjusted EBITDA
|
|
93% target earned
25% Payout
|
|
100% target earned
100% Payout
|
|
108% target earned
200% Payout
|
|
|
|
|
|
|||
|
EMEA Compensation Adjusted EBITDA
|
|
88% target earned
25% Payout
|
|
100% target earned
100% Payout
|
|
112% target earned
200% Payout
|
|
|
|
|
|
|||
|
Corporate Average Working Capital
|
|
98% target earned
50% of Payout
|
|
100% target earned
100% Payout
|
|
105% target earned
200% Payout
|
|
|
|
|
|
|
|
|
|
U.S. Average Working Capital
|
|
97% target earned
50% of Payout
|
|
100% target earned
100% Payout
|
|
105% target earned
200% Payout
|
|
|
|
|
|
|||
|
Canada Average Working Capital
|
|
98% target earned
50% of Payout
|
|
100% target earned
100% Payout
|
|
105% target earned
200% Payout
|
|
|
|
|
|
|||
|
EMEA Average Working Capital
|
|
96% target earned
50% of Payout
|
|
100% target earned
100% Payout
|
|
105% target earned
200% Payout
|
|
|
|
|
|
|||
|
Free Cash Flow
|
|
70% target earned
50% of Payout
|
|
100% target earned
100% of payout
|
|
120% of target earned
200% Payout
|
|
MIP Metric
|
|
2016 Goal
|
|
% Goal
Achieved
|
|
|
Weight
|
|
|
Payout %
Earned
|
|
|
Corporate Compensation Adjusted EBITDA
|
|
$644.6 million
|
|
87.9
|
%
|
|
35
|
%
|
|
0.0
|
%
|
|
Corporate Average Working Capital
|
|
12.2%
|
|
101.0
|
%
|
|
10
|
%
|
|
121.3
|
%
|
|
Corporate Free Cash Flow
|
|
$250 million
|
|
147.1
|
%
|
|
5
|
%
|
|
200.0
|
%
|
|
Management Development and Succession Plans
|
|
various
|
|
187.5
|
%
|
|
50
|
%
|
|
187.5
|
%
|
|
Total
|
|
|
|
|
|
|
|
133.7
|
%
|
||
|
MIP Metric
|
|
2016 Goal
|
|
% Goal
Achieved
|
|
|
Weight
|
|
|
Payout %
Earned
|
|
|
Corporate Compensation Adjusted EBITDA
|
|
$644.6 million
|
|
87.9
|
%
|
|
70
|
%
|
|
0.0
|
%
|
|
Corporate Average Working Capital
|
|
12.2%
|
|
101.0
|
%
|
|
20
|
%
|
|
121.3
|
%
|
|
Corporate Free Cash Flow
|
|
$250 million
|
|
147.1
|
%
|
|
10
|
%
|
|
200.0
|
%
|
|
Total
|
|
|
|
|
|
|
|
44.3
|
%
|
||
|
MIP Metric
|
|
2016 Goal
|
|
% Goal
Achieved
|
|
|
Weight
|
|
|
Payout %
Earned
|
|
|
EMEA Compensation Adjusted EBITDA
|
|
$112.0 million
|
|
105.1
|
%
|
|
50
|
%
|
|
141.4
|
%
|
|
EMEA Average Working Capital
|
|
15.9%
|
|
96.5
|
%
|
|
25
|
%
|
|
53.1
|
%
|
|
Corporate Compensation Adjusted EBITDA
|
|
$644.6 million
|
|
87.9
|
%
|
|
25
|
%
|
|
0.0
|
%
|
|
Total
|
|
|
|
|
|
|
|
84.0
|
%
|
||
|
MIP Metric
|
|
2016 Goal
|
|
% Goal
Achieved
|
|
|
Weight
|
|
|
Payout %
Earned
|
|
|
U.S. Compensation Adjusted EBITDA
|
|
$418.3 million
|
|
80.4
|
%
|
|
50
|
%
|
|
0.0
|
%
|
|
U.S. Average Working Capital
|
|
10.6%
|
|
97.3
|
%
|
|
25
|
%
|
|
52.9
|
%
|
|
Corporate Compensation Adjusted EBITDA
|
|
$644.6 million
|
|
87.9
|
%
|
|
25
|
%
|
|
0.0
|
%
|
|
Total
|
|
|
|
|
|
|
|
13.2
|
%
|
||
|
MIP Metric
|
|
2016 Goal
|
|
% Goal
Achieved
|
|
|
Weight
|
|
|
Payout %
Earned
|
|
|
Canada Compensation Adjusted EBITDA
|
|
$102.3 million
|
|
102.1
|
%
|
|
50
|
%
|
|
126.1
|
%
|
|
Canada Average Working Capital
|
|
9.9%
|
|
119.5
|
%
|
|
25
|
%
|
|
200.0
|
%
|
|
Corporate Compensation Adjusted EBITDA
|
|
$644.6 million
|
|
87.9
|
%
|
|
25
|
%
|
|
0.0
|
%
|
|
Total
|
|
|
|
|
|
|
|
113.0
|
%
|
||
|
MIP Metric
|
|
2016 Goal
|
|
% Goal
Achieved
|
|
|
Weight
|
|
|
Payout %
Earned
|
|
|
Corporate Compensation Adjusted EBITDA
|
|
$644.6 million
|
|
87.9
|
%
|
|
70
|
%
|
|
0.0
|
%
|
|
Corporate Average Working Capital
|
|
12.2%
|
|
101.0
|
%
|
|
30
|
%
|
|
121.3
|
%
|
|
Total
|
|
|
|
|
|
|
|
36.4
|
%
|
||
|
Executive
|
|
Financial
Segment
|
|
MIP Target
% of Base
Salary
|
|
Payout %
of MIP Target
|
|
MIP
Payout
|
|
|
|
Payout %
of
Base Salary
|
||
|
Stephen D. Newlin
|
|
CEO
|
|
136%
|
|
133.8%
|
|
$
|
1,178,535
|
|
|
|
|
107%
|
|
Carl J. Lukach
|
|
CFO
|
|
80%
|
|
48.7%
|
|
$
|
194,920
|
|
|
|
|
39%
|
|
David C. Jukes
|
|
EMEA & U.S.
|
|
80%
|
|
46.9%
|
|
$
|
206,200
|
|
|
|
|
37%
|
|
Michael J. Hildebrand
|
|
Canada
|
|
70%
|
|
113.0%
|
|
$
|
239,553
|
|
|
(1)
|
|
79%
|
|
Stephen N. Landsman
|
|
Corporate
|
|
80%
|
|
40.0%
|
|
$
|
136,136
|
|
|
|
|
32%
|
|
Christopher Oversby
|
|
U.S. & EMEA
|
|
65%
|
|
30.3%
|
|
$
|
101,347
|
|
|
|
|
20%
|
|
(1)
|
Mr. Hildebrand’s incentive is paid in Canadian dollars and is expressed herein in U.S. dollars using a conversion factor of 0.728 (reflects 2016 monthly average exchange rate).
|
|
Name and Principal Position
|
Fiscal
Year
|
Salary
(1)
($)
|
|
Bonus
(2)
($)
|
|
Stock
Awards
($)
|
|
Option
Awards
(3)
($)
|
|
Non-Equity
Incentive Plan
Compen-sation
($)
|
|
Change in
Pension
Value & Non
Qualified Deferred
Comp Earnings
(4)
($)
|
|
All Other
Compen-sation
(5)
($)
|
|
Total
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Stephen D. Newlin
Chairman, President and Chief Executive Officer
|
2016
|
659,552
|
|
157,285
|
|
7,097,513
|
|
|
1,021,251
|
|
|
741,301
|
|
9,676,902
|
|
||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Carl J. Lukach Executive Vice President and Chief Financial Officer
|
2016
|
500,000
|
|
|
1,258,550
|
|
|
194,920
|
|
|
44,100
|
|
1,997,570
|
|
|||
|
2015
|
519,231
|
|
|
|
|
100,000
|
|
|
151,126
|
|
770,357
|
|
|||||
|
2014
|
9,615
|
|
|
|
1,070,000
|
|
|
|
|
1,079,615
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
David C. Jukes President Univar USA and LATAM
(6)
|
2016
|
454,995
|
|
|
936,550
|
|
|
206,200
|
|
136,893
|
|
450,895
|
|
2,185,533
|
|
||
|
2015
|
371,309
|
|
|
|
|
337,579
|
|
|
88,129
|
|
797,017
|
|
|||||
|
2014
|
368,639
|
|
|
467,000
|
|
|
|
429,536
|
|
87,573
|
|
923,212
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Michael J. Hildebrand
President- Canada, Global Agriculture, and Environmental Sciences
(7)
|
2016
|
304,013
|
|
|
386,400
|
|
|
239,553
|
|
424,123
|
|
35,875
|
|
1,389,964
|
|
||
|
2015
|
325,270
|
|
|
|
751,409
|
|
215,794
|
|
111,861
|
|
46,680
|
|
1,451,014
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Stephen N. Landsman Executive Vice President and General Counsel
|
2016
|
425,000
|
|
|
515,200
|
|
|
136,136
|
|
|
29,845
|
|
1,106,181
|
|
|||
|
2015
|
430,038
|
|
|
|
250,485
|
|
56,125
|
|
|
46,740
|
|
783,389
|
|
||||
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
J. Erik Fyrwald Former President and Chief Executive Officer
(8)
|
2016
|
430,769
|
|
|
2,962,400
|
|
338,000
|
|
|
|
60,615
|
|
3,791,785
|
|
|||
|
2015
|
1,034,615
|
|
|
|
|
250,000
|
|
|
114,489
|
|
1,399,105
|
|
|||||
|
2014
|
1,000,000
|
|
|
|
|
588,382
|
|
|
145,451
|
|
1,733,833
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Christopher Oversby
Former President, Univar EMEA
|
2016
|
515,000
|
|
|
193,200
|
|
|
101,347
|
|
|
1,329,531
|
|
2,139,078
|
|
|||
|
2015
|
520,000
|
|
|
|
|
20,600
|
|
|
70,637
|
|
611,237
|
|
|||||
|
2014
|
486,538
|
|
|
934,000
|
|
|
216,000
|
|
|
73,783
|
|
1,710,321
|
|
||||
|
(1)
|
The amount reported for Mr. Newlin in the Salary column includes $29,167 in director fees for the period of 2016 during which Mr. Newlin served as a non-employee director of our Board of Directors.
|
|
(2)
|
The amount reported in this column for Mr. Newlin reflects that Mr. Newlin was entitled to a minimum amount in respect of his 2016 annual cash bonus equal to 80% of the 50% of his annual incentive opportunity that is based on corporate performance goals, prorated to reflect his period of employment in 2016. The amount is equal to the difference of the actual earned for this component and 80% of this portion of the annual incentive opportunity.
|
|
(3)
|
The amount reported for Mr. Newlin in the Stock Awards column includes a grant of restricted stock in respect of Mr. Newlin's service as a director for a portion of 2016 with an aggregate grant date fair value of $100,013. The amount reported is valued based on the aggregate grant date fair value computed in accordance with FASB ASC Topic 718, modified to exclude any forfeiture assumptions related to service-based vesting conditions. See note 9, “Stock-Based Compensation,” to Univar’s audited consolidated financial statements for the year ended
December 31, 2016
included in Univar’s Form 10-K filed with the SEC on
February 28, 2017
for a discussion of the relevant assumptions used in calculating these amounts.
|
|
(4)
|
Pension value represents the year over year compensatory change. The compensatory change for the defined benefit plans includes the service cost for the year and any adjustments to the benefit obligation as a result of salary and bonus changes other than expected. The compensatory changes for the defined benefit plans will differ between years as a result of the discount rate used to calculate the service cost, pay increases other than expected and plan amendments, if any. The 2016 amounts were calculated by using the actual 2016 year-end balance and subtracting the prior year-end balance removing the impact of currency changes year over year.
|
|
(5)
|
The amounts set forth in this column represent contributions made by us under our retirement plans in the amounts of $39,831, $34,600, $13,735, $29,845, $90,999 and $43,281 for Messrs. Newlin, Lukach, Hildebrand, Landsman, Jukes and Oversby, respectively. In addition, for Mr. Jukes, the amounts set forth in this column reflect $68,433 in relocation costs (including airfare, housing and moving expenses) and $7,235 car allowance in connection with his secondment to the U.S. business and a tax equalization payment to him of $284,228. Mr. Newlin’s amount in this column includes $359,055 for commuting expenses to and from Corporate headquarters and other business locations and his residence, $8,810 for legal expenses with his agreements entered into in connection with his appointment as CEO and a gross-up payment to him of $319,605 for his associated taxes. Mr. Newlin’s amount also includes financial planning. For Mr. Hildebrand, the amounts set forth in this column reflect a car allowance of $17,539 and a housing subsidiary of $4,601 which was discontinued effective July 2016. Mr. Lukach’s amount also includes financial planning. For Mr. Oversby, the amounts set forth in this column reflect a severance payment in connection with his termination of employment on December 31, 2016 in an amount equal to $1,127,000, in addition to the following amounts paid during his employment in 2016: $83,250 in relocation costs (including airfare, housing and moving expenses), $6,677 car allowance, and a tax equalization payment of $69,323.
|
|
(6)
|
The amounts reported for Mr. Jukes have been converted from British pounds to U.S. dollars using a 2016 monthly average conversion factor of 1.384. The 2015 and 2014 amounts use a conversion factor of 1.52802.
|
|
(7)
|
The amounts reported for Mr. Hildebrand have been converted from Canadian dollars to U.S. dollars using a 2016 monthly average conversion factor equal to 0.728. The amounts reported for 2015 use a conversion factor of 0.7819.
|
|
(8)
|
For Mr. Fyrwald, the amount reported in the “Option Awards” column for 2016 is the incremental fair value of his modified option award as of May 31, 2016 as a result of the extension of the exercise period of his 894,432 vested options to June 1, 2017. The incremental fair value of these modified options was calculated as of the modification date in accordance with FASB ASC Topic 718, and is equal to the fair value of the modified options on the date of modification minus the fair value of the original award on the date of modification.
|
|
|
|
Estimated Possible Payouts
Under Non-Equity
Incentive Plan Awards
(1)
|
All Other
Stock
Awards:
Number of
Shares or
Stock/
Units
(2)
|
|
All Other
Option
Awards:
Number of
Securities
Underlying
Options (#)
|
|
Exercise
or Base
Price of
Option
Awards
($)
|
Grant
Date Fair
Value of
Stock and
Option
Awards
($)
(3)
|
|
|||||
|
Name
|
Grant
Date
|
Threshold
($)
|
|
Target
($)
|
|
Maximum
($)
|
|
|||||||
|
Stephen D.
Newlin
(4)
|
|
|
|
|
|
|
|
|
||||||
|
MIP
|
|
440,574
|
|
881,148
|
|
1,762,296
|
|
|
|
|
|
|||
|
2015 Equity Plan
|
5/31/2016
|
|
|
|
375,000
|
|
|
|
6,997,500
|
|
||||
|
Carl J. Lukach
|
|
|
|
|
|
|
|
|
||||||
|
MIP
|
|
200,000
|
|
400,000
|
|
800,000
|
|
|
|
|
|
|||
|
2015 Equity Plan
|
2/18/2016
|
|
|
|
60,000
|
|
|
|
772,800
|
|
||||
|
2015 Equity Plan
|
6/3/2016
|
|
|
|
25,000
|
|
|
|
485,750
|
|
||||
|
David C. Jukes
|
|
|
|
|
|
|
|
|
||||||
|
MIP
|
|
220,000
|
|
440,000
|
|
880,000
|
|
|
|
|
|
|||
|
2015 Equity Plan
|
2/18/2016
|
|
|
|
35,000
|
|
|
|
450,800
|
|
||||
|
2015 Equity Plan
|
6/3/2016
|
|
|
|
25,000
|
|
|
|
485,750
|
|
||||
|
Michael J. Hildebrand
|
|
|
|
|
|
|
|
|
||||||
|
MIP
|
|
105,997
|
|
211,994
|
|
423,987
|
|
|
|
|
|
|||
|
2015 Equity Plan
|
2/18/2016
|
|
|
|
30,000
|
|
|
|
386,400
|
|
||||
|
Stephen N. Landsman
|
|
|
|
|
|
|
|
|
||||||
|
MIP
|
|
170,000
|
|
340,000
|
|
680,000
|
|
|
|
|
|
|||
|
2015 Equity Plan
|
2/18/2016
|
|
|
|
40,000
|
|
|
|
515,200
|
|
||||
|
J. Erik Fyrwald
(5)
|
|
|
|
|
|
|
|
|
||||||
|
MIP
|
|
625,000
|
|
1,250,000
|
|
2,500,000
|
|
|
|
|
|
|||
|
2015 Equity Plan
|
2/18/2016
|
|
|
|
230,000
|
|
|
|
2,962,400
|
|
||||
|
2015 Equity Plan
|
5/31/2016
|
|
|
|
|
894,432
|
|
|
338,000
|
|
||||
|
Christopher Oversby
(6)
|
|
|
|
|
|
|
|
|
||||||
|
MIP
|
|
167,375
|
|
334,750
|
|
669,500
|
|
|
|
|
|
|||
|
2015 Equity Plan
|
2/18/2016
|
|
|
|
15,000
|
|
|
|
193,200
|
|
||||
|
(1)
|
For Mr. Newlin, the Estimated Possible Payouts Under Non-Equity Incentive Plan Awards represent the pro-rata 2016 MIP target corresponding to the time he was employed by the Company in 2016.
|
|
(2)
|
A discussion of the Management Incentive Plan for fiscal year
2016
, including bonus amounts paid based on actual performance, can be found under “Compensation Discussion and Analysis- Determination of Executive Officer Compensation- Annual Cash Incentives.” The amounts reported for Mr. Hildebrand have been converted from Canadian dollars using a 2016 monthly average conversion factor of 0.728.
|
|
(3)
|
The RSUs vest in three equal installments on each of the first through third anniversaries of March 5, 2016, except for Mr. Newlin’s RSUs granted in 2016. In connection with Mr. Newlin’s appointment as CEO in 2016, he was granted RSUs in three tranches: one tranche of the RSUs vests monthly over the first 12 months after the grant date, subject to his continued employment; the second tranche of Mr. Newlin’s 2016 RSU grant is subject to the same time-based vesting condition and also the requirement that the closing price of our common stock during any twenty (20) consecutive trading days between the grant date and the third year anniversary of the grant date equals or exceeds $25; and the third tranche of Mr. Newlin’s RSU 2016 grant is subject to the same time-based vesting condition and also the requirement that the closing price of our common stock during any twenty (20) consecutive trading days between the grant date and the fourth year anniversary of the grant date equals or exceeds $30.
|
|
(4)
|
The amounts related to RSUs reported in this column are valued based on the aggregate grant date fair value. See Note 9, “Stock-Based Compensation,” to the Company’s audited consolidated financial statements for the year ended
December 31, 2016
included in Univar’s Form 10-K filed with the SEC on
February 28, 2017
for a discussion of the relevant assumptions used in calculating these amounts.
|
|
(5)
|
Mr. Fyrwald resigned effective May 31, 2016 and forfeited all unvested equity including his 2016 grant of RSUs. Pursuant to Mr. Fyrwald’s separation and release agreement, the exercise date of Mr. Fyrwald’s 894,432 vested options was extended to June 1, 2017. The amount reported in the “Grant Date Fair Value of Stock and Option Awards” column in respect of this option award modification is the incremental fair value of his modified option award as of the May 31, 2016 modification date, calculated in accordance with FASB ASC Topic 718, and is equal to the fair value of the modified options on the date of modification minus the fair value of the original award on the date of modification.
|
|
(6)
|
Mr. Oversby's employment terminated effective December 31, 2016, and he forfeited all of the 2016 grant of RSUs as of the termination date.
|
|
Executive
|
|
By the Company for “Cause or by Executive for Good Reason”
|
|
Death or Disability
|
|
Lukach /
Landsman
|
|
• Lump sum payment equal to the sum of his annual base salary plus his target bonus
|
|
• Prorated target bonus for the year of terminations.
|
|
Name
|
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
|
|
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
|
Option
Exercise
Price
($)
|
|
Option
Expiration
Date
|
Number of
Shares or
Units of
Stock that
Have Not
Vested (#)
|
Market Value
of Shares or
Units that
Have Not
Vested ($)
(1)
|
|
|
Stephen D. Newlin
|
|
|
|
|
52,085
(2)
|
1,477,651
|
|
||
|
|
|
|
|
125,000
(3)
|
3,546,250
|
|
|||
|
|
|
|
|
125,000
(4)
|
3,546,250
|
|
|||
|
J. Erik Fyrwald
|
705,468
|
|
|
23.06
|
|
5/31/2017
(5)
|
|
|
|
|
|
188,964
|
|
|
21.08
|
|
5/31/2017
(5)
|
|
|
|
|
Carl J. Lukach
|
62,988
|
|
62,989
(6)
|
23.60
|
|
12/8/2024
|
60,000
(7)
|
1,702,200
|
|
|
|
|
|
|
|
25,000
(8)
|
709,250
|
|
||
|
David C. Jukes
|
128,103
|
|
|
19.85
|
|
3/28/2021
|
12,598
(10)
|
357,405
|
|
|
|
|
|
|
|
35,000
(7)
|
992,950
|
|
||
|
|
|
|
|
|
25,000
(8)
|
709,250
|
|
||
|
Michael J. Hildebrand
|
55,697
|
|
|
19.85
|
|
3/28/2021
|
30,000
(7)
|
851,100
|
|
|
27,871
|
|
83,614
(9)
|
20.76
|
|
2/18/2025
|
|
|
||
|
Stephen N. Landsman
|
62,989
|
|
|
14.29
|
|
8/8/2023
|
40,000
(7)
|
1,134,800
|
|
|
100,782
|
|
|
14.53
|
|
11/12/2023
|
|
|
||
|
9,291
|
|
27,873
(9)
|
20.76
|
|
2/18/2025
|
|
|
||
|
Christopher Oversby
|
151,172
|
|
|
21.08
|
|
11/30/2022
|
25,195
(10)
|
714,782
|
|
|
50,391
|
|
|
14.29
|
|
8/8/2023
|
15,000
(7)
|
425,550
|
|
|
|
(1)
|
Closing price of $28.37 per share of Univar common stock on the NYSE on December 31, 2016.
|
|
(2)
|
The award vests in twelve equal installments on each of the first through twelve monthly anniversaries of May 31, 2016.
|
|
(3)
|
The award vests in twelve equal installments on each of the first through twelve anniversaries of May 31, 2016 and the stock price has met or exceeded $25.00 for twenty consecutive trading days with three years to reach performance achievement.
|
|
(4)
|
The award vests in twelve equal installments on each of the first through twelve anniversaries of May 31, 2016 and the stock price has met or exceeded $30.00 for twenty consecutive trading days with four years to reach performance achievement.
|
|
(5)
|
In connection with Mr. Fyrwald’s resignation and in exchange for certain agreed changes to his noncompetition and nonsolicitation covenants and a release of employee claims, his then vested options were extended to June 1, 2017.
|
|
(6)
|
The award vests in four equal installments on each of the first through fourth anniversaries of December 8, 2014, subject to continued employment.
|
|
(7)
|
The award vests in three equal installments on each of the first through third anniversaries of March 5, 2016, subject to continued employment.
|
|
(8)
|
The award vests in one installment on May 31, 2019, subject to continued employment.
|
|
(9)
|
The award vests in four equal installments on each of the first through fourth anniversaries of February 18, 2015, subject to continued employment.
|
|
(10)
|
The award vests in four equal installments on each of the first through fourth anniversaries of February 3, 2014, subject to continued employment. Upon Mr. Oversby's termination of employment on December 31, 2016, 11,428 shares related to this award vested per the terms of his award agreement; the remaining 13,767 shares were forfeited.
|
|
|
|
Option Award
|
|
Stock Award
|
||||||
|
Name
|
|
Number of
Shares
Acquired on
Exercise (#)
|
|
|
Value
Realized on
Exercise
($)
|
|
Number of
Shares
Acquired on
Vesting (#)
|
|
|
Value Realized
on Vesting ($)
|
|
Stephen D. Newlin
|
|
|
|
|
|
10,416
|
|
|
196,967
(1)
|
|
|
|
|
|
|
|
|
10,416
|
|
|
190,717
(2)
|
|
|
|
|
|
|
|
|
10,416
|
|
|
215,507
(3)
|
|
|
|
|
|
|
|
|
10,416
|
|
|
227,590
(4)
|
|
|
|
|
|
|
|
|
10,417
|
|
|
231,778
(5)
|
|
|
|
|
|
|
|
|
10,417
|
|
|
259,383
(6)
|
|
|
|
|
|
|
|
|
10,417
|
|
|
295,530
(7)
|
|
|
|
|
|
|
|
|
|
|
|
||
|
David C. Jukes
|
|
|
|
|
|
6,299
|
|
|
73,761
(8)
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Christopher Oversby
|
|
4,480
|
|
|
26,611
(9)
|
|
12,598
|
|
|
147,523
(17)
|
|
|
|
841
|
|
|
4,659
(10)
|
|
11,428
|
|
|
324,212
(18)
|
|
|
|
4,467
|
|
|
24,747
(11)
|
|
|
|
|
|
|
|
|
18,362
|
|
|
108,899
(12)
|
|
|
|
|
|
|
|
|
3,448
|
|
|
19,940
(13)
|
|
|
|
|
|
|
|
|
18,793
|
|
|
107,325
(14)
|
|
|
|
|
|
|
|
|
98,302
|
|
|
493,451
(15)
|
|
|
|
|
|
|
|
|
52,870
|
|
|
281,730
(16)
|
|
|
|
|
|
|
(1)
|
Reflects the vesting of a portion of the RSUs granted to Mr. Newlin. The value realized on vesting was calculated based on a per share fair market value of $18.91 on the vesting date of June 30, 2016.
|
|
(2)
|
Reflects the vesting of a portion of the RSUs granted to Mr. Newlin. The value realized on vesting was calculated based on a per share fair market value of $18.31 on the vesting date of July 31, 2016.
|
|
(3)
|
Reflects the vesting of a portion of the RSUs granted to Mr. Newlin. The value realized on vesting was calculated based on a per share fair market value of $20.69 on the vesting date of August 31, 2016.
|
|
(4)
|
Reflects the vesting of a portion of the RSUs granted to Mr. Newlin. The value realized on vesting was calculated based on a per share fair market value of $21.85 on the vesting date of September 30, 2016.
|
|
(5)
|
Reflects the vesting of a portion of the RSUs granted to Mr. Newlin. The value realized on vesting was calculated based on a per share fair market value of $22.25 on the vesting date of October 31, 2016.
|
|
(6)
|
Reflects the vesting of a portion of the RSUs granted to Mr. Newlin. The value realized on vesting was calculated based on a per share fair market value of $24.90 on the vesting date of November 30, 2016.
|
|
(7)
|
Reflects the vesting of a portion of the RSUs granted to Mr. Newlin. The value realized on vesting was calculated based on a per share fair market value of $28.37 on the vesting date of December 31, 2016.
|
|
(8)
|
Reflects the vesting of a portion of the restricted stock granted to Mr. Jukes. The value realized on vesting was calculated based on a per share fair market value of $11.71 on the vesting date of February 3, 2016.
|
|
(9)
|
Reflects the value of the exercise based on the fair market value of $20.23 on the exercise date of September 19, 2016.
|
|
(10)
|
Reflects the value of the exercise based on the fair market value of $19.83 on the exercise date of September 20, 2016.
|
|
(11)
|
Reflects the value of the exercise based on the fair market value of $19.83 on the exercise date of September 20, 2016.
|
|
(12)
|
Reflects the value of the exercise based on the fair market value of $20.22 on the exercise date of September 19, 2016.
|
|
(13)
|
Reflects the value of the exercise based on the fair market value of $20.07 on the exercise date of September 20, 2016.
|
|
(14)
|
Reflects the value of the exercise based on the fair market value of $20.00 on the exercise date of September 20, 2016.
|
|
(15)
|
Reflects the value of the exercise based on the fair market value of $26.10 on the exercise date of December 16, 2016.
|
|
(16)
|
Reflects the value of the exercise based on the fair market value of $26.41 on the exercise date of December 19, 2016.
|
|
(17)
|
Reflects the vesting of a portion of the restricted stock granted to Mr. Oversby. The value realized on vesting was calculated based on a per share fair market value of $11.71, on the vesting date of February 3, 2016.
|
|
(18)
|
Reflects the vesting of a portion of the restricted stock held by Mr. Oversby upon his separation of employment pursuant to the terms of his restricted stock award agreement. The value realized on vesting was calculated based on a per share fair market value of $28.37 on the vesting date of December 31, 2016.
|
|
Name
|
|
Plan Name
|
|
Number of
Years
Credited
Service
|
|
|
Present Value
Accumulated
Benefits
|
|
|
|
|
Payments
During Last
Fiscal Year
($)
|
|
|
Michael J. Hildebrand
|
|
Univar Canada Ltd.
Pension Plan (DB RPP)
|
|
23.50
|
|
|
$
|
505,019
|
|
|
(1)(2)
|
|
$0
|
|
Michael J. Hildebrand
|
|
Supplemental Retirement
Plan (DB SBP)
|
|
25.00
|
|
|
$
|
855,873
|
|
|
(1)(2)
|
|
$0
|
|
David C. Jukes
|
|
Univar Company Pension
Scheme (1978)
|
|
9.25
|
|
|
$
|
763,877
|
|
|
(3)(4)
|
|
$0
|
|
(1)
|
These figures reflect the estimated present value of Mr. Hildebrand’s pension benefits accrued through December 31, 2016. The figures were calculated using the following key assumptions: liability discount rate of 3.85% per year for the DB RPP and 3.65% per year for the DB SBP, retirement at age 62, rate of salary increases of 0% per year, rate of inflation of 0% per year and mortality in accordance with the 2014 Private Sector Canadian Pensioners’ Mortality (“CPM”) table projected generationally using CPM Improvement Scale B. The data, assumptions and methods are the same as those used for purposes of reporting the defined benefit obligations for Univar Canada Ltd. in the Company’s audited financial statements for the year ended
December 31, 2016
that are included in the Company’s Form 10-K filed with the SEC on
February 28, 2017
.
|
|
(2)
|
The amounts reported for Mr. Hildebrand have been converted from Canadian dollars using the 2016 average monthly conversion factor of 0.728.
|
|
(3)
|
This figure reflects the estimated present value of Mr. Jukes' pension benefits accrued through December 31, 2016. This figure was calculated using the following assumptions: mortality of zero prior to retirement age, benefit commencement at normal retirement age of 60, all other data, assumptions, methods, and provisions are the same as those used for the ASC715 year-end disclosures for the Univar Company Pension Scheme (1978).
|
|
(4)
|
The amount reported for Mr. Jukes has been converted from British pounds using the 2016 average monthly conversion factor of 1.384.
|
|
Name
|
|
Executive
Contributions
in Last Fiscal
Year ($)
(1)
|
|
|
Company
Contributions
in Last Fiscal
Year ($)
(2)
|
|
|
Aggregate
Earnings
in Last
Fiscal
Year ($)
(3)
|
|
|
Aggregate
Withdrawals/
Distributions
($)
|
|
Aggregate
Balance at
Last Fiscal
Year End ($)
(4)
|
|
|
Stephen D. Newlin
|
|
65,571
|
|
|
112,989
|
|
|
1
|
|
|
0
|
|
23,692
|
|
|
J. Erik Fyrwald
|
|
20,308
|
|
|
19,415
|
|
|
112,025
|
|
|
0
|
|
887,915
|
|
|
Carl J. Lukach
|
|
29,238
|
|
|
24,994
|
|
|
467
|
|
|
0
|
|
7,559
|
|
|
Stephen N. Landsman
|
|
0
|
|
|
11,845
|
|
|
35,444
|
|
|
0
|
|
544,966
|
|
|
Christopher Oversby
|
|
128,337
|
|
|
28,541
|
|
|
33,703
|
|
|
0
|
|
411,521
|
|
|
(1)
|
Amounts in this column include contributions associated with base salary and bonus amounts earned in 2016. These amounts are also included in “Salary”, "Bonus" and/or “Non-Equity Incentive Plan Compensation” for fiscal year
2016
in the Summary Compensation Table.
|
|
(2)
|
Amounts in this column are included in “All Other Compensation” for fiscal year
2016
in the Summary Compensation Table. Company contributions associated with the
2015
bonus, paid in
2016
, are not included in this column because that bonus was accrued in respect of
2015
service. Contributions associated with the
2016
bonus, paid in
2017
, are included because that bonus was accrued in respect of
2016
service.
|
|
(3)
|
The aggregate earnings represent the market value change during fiscal year
2016
of the Deferred Compensation Plan. Because the earnings are not preferential or above-market, they are not included in the Summary Compensation Table.
|
|
(4)
|
Amounts in this column represent December 31, 2016 account balances without consideration for 2016 accrued contributions.
|
|
Name
|
|
Termination due
to Death or
Disability ($)
|
|
|
|
Termination
Without Cause by
the Company or by the NEO
for Good Reason ($)
|
|
|
||
|
Stephen D. Newlin
|
|
0
|
|
|
|
|
2,600,000
|
|
|
(2)
|
|
Carl J. Lukach
|
|
400,000
|
|
|
(1)
|
|
900,000
|
|
|
(3)
|
|
David C. Jukes
|
|
440,000
|
|
|
(1)
|
|
990,000
|
|
|
(3)
|
|
Michael J. Hildebrand
|
|
0
|
|
|
|
605,696
|
|
|
(4)
|
|
|
Stephen N. Landsman
|
|
340,000
|
|
|
(1)
|
|
765,000
|
|
|
(3)
|
|
Christopher Oversby
|
|
0
|
|
|
|
1,127,000
|
|
|
(5)
|
|
|
(1)
|
Represents a lump sum cash payment equal to the target bonus for the year of termination.
|
|
(2)
|
Represents the sum of (i) his annual base salary plus (ii) his target bonus amount, payable in 12 monthly installments, provided that his employment is not terminated as a result of a succession process (as defined in his employment agreement).
|
|
(3)
|
Represents a lump sum cash payment equal to the sum of (i) his annual base salary plus (ii) his target bonus amount.
|
|
(4)
|
Represents required payment under Canadian law of a lump sum cash payment equal to the sum of two times his annual base salary. Amounts converted from Canadian dollars to U.S. dollars at a rate of 0.728.
|
|
(5)
|
Represents actual amount of severance paid to Mr. Oversby in connection with his termination of employment on December 31, 2016, which is the sum of (i) his annual base salary, (ii) an amount equal to his prior period target incentive of 80% salary under the Company’s Management Incentive Plan and (iii) an additional amount equal to $200,000 in respect of the former energy vertical bonus.
|
|
•
|
any transaction that would result in the direct or indirect beneficial ownership by any person, entity or “group” (as defined in Section 13(d) of the Exchange Act, as amended), excluding the Company, any of its subsidiaries, any of the Company’s or it’s subsidiary’s employee benefit plan, and CD&R Univar Holdings, L.P. or any of its affiliates (and any “group” that includes any of the foregoing and any member of such group), or any affiliates of any of the foregoing, of more than 50% of the combined voting power of the Company’s then outstanding voting securities; excluding an acquisition immediately following which CD&R Univar Holdings, L.P. owns at least 10% of the outstanding shares of Company stock;
|
|
•
|
within any 12-month period, the persons who were members of the Board of Directors at the beginning of such period cease to constitute at least a majority of the Board of Directors; or
|
|
•
|
the sale, transfer or other disposition of all or substantially all of the assets of the Company to one or more persons or entities that are not, immediately prior to such sale, transfer or other disposition, affiliates of the Company.
|
|
•
|
the acquisition by any person, entity or “group” (as defined in Section 13(d) of the Securities Exchange Act of 1934, as amended) of 50% or more of the combined voting power of the Company’s then outstanding voting securities, other than any such acquisition by the Company, any of its subsidiaries, any associate benefit plan of the Company or any of its subsidiaries, or by CD&R Univar Holdings, L.P. or any of its affiliates, excluding an acquisition immediately following which CD&R Univar Holdings, L.P. owns at least 10% of the outstanding shares of Company stock;
|
|
•
|
within any 12-month period, the persons who were members of the Board of Directors at the beginning of such period cease to constitute at least a majority of the Board of Directors; or
|
|
•
|
the sale, transfer or other disposition of all or substantially all of the Company’s assets to one or more persons or entities that are not, immediately prior to such sale, transfer or other disposition, affiliates of the Company.
|
|
Name
|
|
Termination due to
Death or Disability
(1)
($)
|
|
|
Termination Without
Cause or for Good Reason
(2)
($)
|
|
|
Change in Control
(1)(3)
($)
|
|
|
|
|
|
|
|
|
|
|||
|
Stephen D. Newlin
|
|
1,477,651
|
|
|
0
|
|
|
1,477,651
|
|
|
Carl J. Lukach
|
|
615,991
|
|
|
9,468
|
|
|
2,711,908
|
|
|
Stephen N. Landsman
|
|
373,143
|
|
|
61,215
|
|
|
1,346,914
|
|
|
Michael J. Hildebrand
|
|
417,589
|
|
|
183,622
|
|
|
1,487,403
|
|
|
David C. Jukes
|
|
573,585
|
|
|
162,049
|
|
|
2,059,605
|
|
|
Christopher Oversby
(4)
|
|
n/a
|
|
|
324,212
|
|
|
n/a
|
|
|
(1)
|
For Messrs. Lukach, Hildebrand, Landsman and Jukes, the amounts represent the value of the stock options (and, for Mr. Jukes, the value of the restricted stock) that would have vested pursuant to the 2011 Equity Plan and applicable award agreements, and the value of the RSUs that would have vested pursuant to the 2015 Equity Plan and applicable award agreements, in each case as of December 31, 2016, calculated as follows: the number of awards held by the employee that would have vested if employment with the Company had continued until the next anniversary date multiplied by a fraction where the numerator is number of days from the anniversary of the grant date to December 31 and the denominator is 365. As described above, for Mr. Newlin, the amounts reflected in the table include the value of all unvested amounts of RSUs in the tranche that is exclusively time-based. All values were determined using the $28.37, the closing stock price at December 30, 2016.
|
|
(2)
|
For Messrs. Lukach, Hildebrand, Landsman and Jukes, these amounts represent the value of the stock options (and, for Mr. Jukes, the value of the restricted stock) that would have vested pursuant to the 2011 Equity Plan and applicable award agreements as of such date, calculated as follows: the number of awards held by the employee that would have vested if employment with the Company had continued until the next anniversary date multiplied by a fraction where the numerator is number of days from the anniversary of the grant date to December 31 and the denominator is 365. Values were determined using $28.37, the closing stock price at December 30, 2016. Any outstanding RSUs under the 2015 Equity Plan do not accelerate due to a termination of employment without Cause or Good Reason alone without a preceding change in control.
|
|
(3)
|
For Messrs. Lukach, Hildebrand, Landsman, Jukes and Oversby, all restricted stock awards and stock options outstanding under the 2011 Equity Plan vest upon a change in control. For Mr. Newlin’s RSUs granted in 2016 under the 2015 Equity Plan, all unvested RSUs that are exclusively time-based would have vested upon a change in control and the performance-based RSUs for which the stock price condition was satisfied would have vested upon a change in control. For the NEOs other than Mr. Newlin, unvested RSUs granted under the 2015 Equity Plan will not automatically vest as a result of the change in control; these unvested awards would continue their normal vesting schedules, unless the NEO’s employment were to be terminated without “cause” or for “good reason” within eighteen (18) months after the change in control or three (3) months preceding the change in control. Values were determined using $28.37, the closing stock price at December 30, 2016.
|
|
(4)
|
Amounts reported for Mr. Oversby reflect the actual treatment of his outstanding equity upon his termination of employment on December 31, 2016, including the vesting of 11,428 shares of restricted stock pursuant to the terms of his restricted stock award agreement. Any unvested equity held by Mr. Oversby at the time of his termination of employment, including awards that did not vest upon his termination pursuant to the terms of his award agreements and all of his RSUs granted in 2016 under the 2015 Equity Plan, were forfeited effective as of December 31, 2016.
|
|
Name
|
Fees Earned
or Paid in Cash $ (1) |
|
Stock
Awards $ (2) |
|
|
Option
Awards $ |
Change in Pension
Value and Non Qualified Deferred Compensation Earnings $ |
|
|
All other
Compensation $ |
|
Total
$ |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Mark J. Byrne
|
77,500
|
|
100,013
|
|
|
|
|
|
|
(3)
|
177,513
|
|
|
|
Daniel P. Doheny
|
52,083
|
|
200,007
|
|
|
|
|
|
|
|
252,090
|
|
|
|
Richard P. Fox
|
97,500
|
|
100,013
|
|
|
|
74,566
|
|
(4)
|
|
|
197,513
|
|
|
Lars Haegg
|
—
|
|
—
|
|
(5)
|
|
|
|
|
|
—
|
|
|
|
Richard Jalkut
|
24,306
|
|
—
|
|
(6)
|
|
|
|
|
|
24,306
|
|
|
|
George Jaquette
|
—
|
|
—
|
|
(7)
|
|
|
|
|
|
—
|
|
|
|
Edward J. Mooney
|
23,118
|
|
169,387
|
|
|
|
|
|
|
|
192,505
|
|
|
|
Stephen D. Newlin
(8)
|
—
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
Christopher D. Pappas
|
78,333
|
|
100,013
|
|
|
|
|
|
|
|
178,346
|
|
|
|
Stephen W. Shapiro
|
—
|
|
100,013
|
|
(9)
|
|
|
|
|
|
100,013
|
|
|
|
Christopher Stadler
|
44,220
|
|
—
|
|
(5)
|
|
|
|
|
|
44,220
|
|
|
|
William S. Stavropoulos
|
87,500
|
|
100,013
|
|
|
|
|
|
|
|
187,513
|
|
|
|
Juliet Teo
|
72,250
|
|
100,013
|
|
(10)
|
|
|
|
|
|
172,263
|
|
|
|
Robert L. Wood
|
23,118
|
|
169,387
|
|
|
|
|
|
|
|
192,505
|
|
|
|
David H. Wasserman
|
87,500
|
|
100,013
|
|
(11)
|
|
|
|
|
|
141,568
|
|
|
|
(1)
|
Represents the Director retainer fees earned in
2016
.
|
|
(2)
|
The amounts in this column represent the grant date fair value of restricted stock awarded (rounded up to the nearest full share) for the annual director retainer and new director grants in accordance with the Directors Compensation Policy in effect at the time of grant. Mr. Doheny received a new director grant. The annual director retainer for Mr. Mooney and Mr. Wood was prorated for their October 5, 2016 start date. The following restricted stock awards were at a fair value of $16.68 per share: Mr. Byrne (5,996 shares); Mr. Doheny (10,707 shares); Mr. Fox (5,996 shares); Mr. Newlin (5,996 shares); Mr. Pappas (5,996 shares); Mr. Shapiro (5,996 shares); Ms. Teo (5,996 shares); and Mr. Wasserman (5,996 shares). The following restricted stock awards were at a fair value of $22.70 per share: Mr. Mooney (7,462 shares); and Mr. Wood (7,462 shares).
|
|
(3)
|
Mr. Byrne was also an employee of the Company though January 31, 2015 and entered into a consulting agreement. He earned $249,996 as compensation for these consulting services in 2016. Mr. Byrne has 251,953 vested options outstanding and unexercised.
|
|
(4)
|
Amount reported represents the actuarial increase of the benefit that Mr. Fox has in his defined benefit pension plan arrangement during the last fiscal year, based on measurement dates of December 31, 2015 and December 31, 2016. The actual amount is $74,556. This increase is primarily due to the decrease in the discount rate from 4.68
%
to 4.36
%
. This figure was calculated using the following assumptions: (1) mortality of zero prior to retirement age, (2) benefit
|
|
(5)
|
Cash awards for Mr. Haegg and Mr. Stadler were assigned to CVC Capital Partners Advisory (US) Inc. Mr. Haegg and Mr. Stadler did not receive equity awards in 2016. Mr. Haegg and Mr. Stadler resigned on August 18, 2016.
|
|
(6)
|
Mr. Jalkut did not stand for re-election at the May 5, 2016 annual meeting of shareholders.
|
|
(7)
|
Mr. Jaquette resigned from the Board of Directors on March 28, 2016.
|
|
(8)
|
Mr. Newlin was appointed President and Chief Executive Officer of Univar Inc. effective June 1, 2016, and as of that date became an employee director. Mr. Newlin's compensation for 2016 services as a director is included in the summary compensation table, as required by SEC rules.
|
|
(9)
|
CD&R Univar Holdings L.P. waived Mr. Shapiro's cash retainer, and his director restricted stock awards are assigned to Clayton, Dubilier & Rice, LLC.
|
|
(10)
|
Cash awards to Ms. Teo have been assigned to Temasek International Ltd. Restricted awards to Ms. Teo have been assigned to Dahlia Investments Pte. Ltd.
|
|
(11)
|
Cash and restricted stock awards for Mr. Wasserman are assigned to Clayton, Dubilier & Rice, LLC.
|
|
|
|
Total Shares Available under Equity Plans
|
|
Equity Dilution: Percent
of Outstanding Shares of Common Stock
(1)
|
|
Shares authorized for future awards under the 2015 Equity Plan as of March 8, 2017
|
|
1,222,760
|
|
0.9%
|
|
Additional shares that will become available under the 2017 Equity Plan
|
|
6,000,000
|
|
4.3%
|
|
Total shares authorized for future awards after stockholder approval of the 2017 Equity Plan (ignoring permitted recycling of cancelled shares)
|
|
7,222,760
|
|
5.2%
|
|
(1) Uses shares of common stock outstanding of 139,846,144 shares as of February 10, 2017, as reported in our Annual Report on Form 10-K for the year ended December 31, 2016.
|
||||
|
Plan Category
|
Number of Securities to be Issue Upon Exercise of Outstanding Options, Warrants and Rights
(1)
|
Weighted Average Exercise Price of Outstanding Options
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in first column)
|
||
|
Equity compensation plans approved by shareholders
|
—
|
$
|
—
|
|
—
|
|
Equity compensation plans not approved by shareholders
|
4,644,620
|
$
|
20.03
|
|
2,606,318
|
|
Total
|
4,644,620
|
$
|
20.03
|
|
2,606,318
|
|
(1) The figures in this column reflect 3,634,733 stock options and 1,009,887 RSUs granted to participants pursuant to both the 2015 Equity Plan and 2011 Equity Plan. The amounts do not include 86,197 restricted shares outstanding as of December 31, 2016.
|
|||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Sonoco Products Company | SON |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|